QC

ALIMENTATION COUCHE-TARD TO ROLL OUT "SMART CHECKOUT" TO MORE THAN 7,000 CIRCLE K AND COUCHE-TARD STORES ACROSS GLOBAL NETWORK USING MASHGIN'S AI-POWERED TECHNOLOGY

Retrieved on: 
Thursday, June 2, 2022
Time, Global Innovation through Science and Technology initiative, Transport, Legislation, NEA, AI, CEO, Airport, Alimentation Couche-Tard, Multimedia, Intelligence, Sale, McGill University, Note, Technology, Projection, SIP, TSX, Twitter, Industry, Operation, PALO, Y Combinator, Intention, Matrix Partners, LinkedIn, View, Online shopping, Circle, QC, Circle K

Referred to as "Smart Checkout" in Circle K and Couche-Tard stores, the Mashgin Touchless Checkout System is a compact countertop device that fits easily into the existing store layout.

Key Points: 
  • Referred to as "Smart Checkout" in Circle K and Couche-Tard stores, the Mashgin Touchless Checkout System is a compact countertop device that fits easily into the existing store layout.
  • It uses computer vision to recognize items presented from virtually any angle and instantly ring them up in a single transaction.
  • Customers place their items on the Mashgin Touchless Checkout System, which uses cameras to ring up everything in under a second.
  • Mashgin Chief Technology Officer and co-founder, Mukul Dhankar stated, "Mashgin's core technology represents a major breakthrough in the world of artificial intelligence.

On One Year Anniversary, Organon Introduces Global Environmental, Social and Governance (ESG) Strategy and Commitments with Publication of Inaugural ESG Report

Retrieved on: 
Thursday, June 2, 2022
Woman, Life, Goal, Conference, Gender representation on corporate boards of directors, Man, Ethics, Endometriosis, ESG, OGN, Education, Gaps, Biophysical environment, Investment, Menopause, Reproductive health, Program, Internal bleeding, NYSE, Birth certificate, Board, Pregnancy, Promise, Social services, Gender, Scout leader, Fertility, Carbon, Lithium, Birth control, Health, QC, Organon

The ESG Report was developed by Organon, Organon Canada Inc.'s parent company, to disclose the company's priorities and areas of focus.

Key Points: 
  • The ESG Report was developed by Organon, Organon Canada Inc.'s parent company, to disclose the company's priorities and areas of focus.
  • As the only global women's healthcare company of its kind, Organon is well positioned to help address several current and growing women's health challenges.
  • For example, nearly half of all pregnancies worldwide about 121 million in total are unintended, including in Canada.
  • For more details on Organon's ESG strategy, priorities, and initiatives, download the full 2021 ESG Report here .

BRP CHOOSES TO RIDE OUT INTIMIDATION

Retrieved on: 
Wednesday, June 1, 2022
Zero, Ride Out, Company, Friends, Program, BRP, School, Mental health, Sea-Doo, Corporate social responsibility, Born This Way Foundation, Forward-looking statement, CEO, Intimidation, Environment, Awareness, Founder CEO, Organization, Workforce, Label, Emotion, Violence, TSX, Movement, Bullying, NASDAQ, Phrase, Industry, Learning, Fruit, Ski-Doo, Family, Ditch the Label, Foundation, Uncertainty, Workplace, Terminology, Toy, Management, Pharmaceutical industry, Risk management, Manitou, Rotax, Ethics, QC, Lynx

"We choose to take a stand against intimidation, a prevalent social challenge that unfortunately still touches too many, everywhere and in different ways," declared Jos Boisjoli, President and CEO at BRP.

Key Points: 
  • "We choose to take a stand against intimidation, a prevalent social challenge that unfortunately still touches too many, everywhere and in different ways," declared Jos Boisjoli, President and CEO at BRP.
  • As a starting point, BRP is joining forces with three reputable organizations that are experts in fighting intimidation: Born this Way Foundation, Ditch the Label, and the Jasmin Roy Sophie Desmarais Foundation.
  • "We are grateful to BRP and their Ride Out Intimidation initiative for supporting our work and contributing to a kinder and braver world."
  • Charitable organizations are encouraged to submit their projects related to Ride Out Intimidation via the BRP website .

BRP Makes Executive Appointments Supporting its Future Growth

Retrieved on: 
Tuesday, May 31, 2022
Senior, Company, Goal, Uncertainty, NASDAQ, Myron Hunt, Strategic management, TSX, CTO, CIO, Mariner Group, Industry, BRP, Forward-looking statement, EV, Terminology, Technology, Tran, Acquisition, Sea-Doo, Growth, Phrase, QC, Ski-Doo, CEO, Renewable energy, Management, Risk management, Rotax, Manitou, Lynx, Powersports

VALCOURT, QC, May 31, 2022 /PRNewswire/ -BRP Inc. (TSX: DOO) (NASDAQ: DOOO) announces today executive appointments to support future growth plans, build an even more resilient company and deliver lasting value.

Key Points: 
  • VALCOURT, QC, May 31, 2022 /PRNewswire/ -BRP Inc. (TSX: DOO) (NASDAQ: DOOO) announces today executive appointments to support future growth plans, build an even more resilient company and deliver lasting value.
  • This evolution of the leadership structure will allow BRP to continue focusing on its long-term goals and achieve its ambitious targets.
  • "In the past five years alone, our revenues increased by 80%, and our employee base more than doubled.
  • Uhr and his team will look to the future, spearheading all new product and manufacturing technologies used across the Powersports and Marine businesses, including the EV program.

OneCellDx and Genetics Institute of America Partner to Launch OncoPredikt HRD Assay

Retrieved on: 
Tuesday, May 31, 2022
Research, General Health, Pharmaceutical, Oncology, Medical Devices, Technology, Genetics, Science, Nanotechnology, Biotechnology, Medical Supplies, Health, Longevity, DNA, Neoplasm, Leadership, Multimedia, Patient, Genetic testing, Quality of life, LDT, Society, Genetics, Algorithm, Protein, Research, Awareness, RNA, Technology, Biomarker, ASCO, Genetics Institute, CLIA, Founder, Cancer, HRD, QC, CA, CEO, Pharmaceutical industry, Vaccine

OneCellDx and Genetics Institute of America announced today that they have signed a memorandum of understanding for a diagnostics commercialization agreement for the OneCellDx OncoPredikt HRD Assay.

Key Points: 
  • OneCellDx and Genetics Institute of America announced today that they have signed a memorandum of understanding for a diagnostics commercialization agreement for the OneCellDx OncoPredikt HRD Assay.
  • Genetics Institute of America will create a laboratory developed test (LDT) based on OneCellDxs proprietary AI Enabled Algorithm and assay.
  • Our team of scientists and engineers have developed a uniquely impactful solution and are very excited to partner with the team at Genetics Institute of America in bringing OncoPredikt HRD to market, said Mohan Uttarwar, Co-founder and CEO of OneCellDx.
  • Genetics Institute of America and OneCellDx will launch the LDT through HRD Pharma Development programs.

Pillar Biosciences Announces Online Publication of Data in the Journal of Clinical Oncology

Retrieved on: 
Tuesday, May 31, 2022
Biotechnology, Medical Devices, Health, Pharmaceutical, Oncology, Pillar, WES, Physician, NGS, Company, CNV, Annual general meeting, Journal, Patient, Genetic testing, IVD, RUO, Society, American Society of Clinical Oncology, FDA, Efficiency, Recurrence, List of life sciences, Sequence, Technology, Liquid biopsy, ASCO, Genomics, American Journal of Clinical Oncology, Cancer, QC, Diagnosis, Cdx, CEO, Pharmaceutical industry, Medical imaging, Column

The company will also be showcasing its highly accurate and sensitive NGS genetic testing technology at booth #17157 June 4 through June 6, 2022.

Key Points: 
  • The company will also be showcasing its highly accurate and sensitive NGS genetic testing technology at booth #17157 June 4 through June 6, 2022.
  • There is a critical need for NGS tests that can accurately and rapidly identify somatic variants in cancer patients.
  • Current NGS tests can have high failure rates which delay the return of actionable results to physicians, significantly impacting time to diagnosis and critical treatment decisions, said Randy Pritchard, CEO of Pillar Biosciences.
  • We are pleased that this study has been published online and look forward to demonstrating the capabilities of our NGS genetic testing solutions at ASCO.

Competition Bureau reaches agreement with Rogers and Shaw to prohibit closing pending the outcome of the Commissioner's application to challenge merger

Retrieved on: 
Monday, May 30, 2022
Competition, Competition Tribunal, Competition Bureau, Hearing, Bell, Tribunal, Bureau, Acquisition, Commissioner, QC, Ridesharing company, Telus

Rogers and Shaw have also agreed to the Commissioner's request for an expedited hearing process before the Tribunal.

Key Points: 
  • Rogers and Shaw have also agreed to the Commissioner's request for an expedited hearing process before the Tribunal.
  • The Commissioner sought an expedited process given the ongoing harm he has alleged is already occurring in the market.
  • On May 9th, the Competition Bureau filed an application with the Tribunal seeking a court order to block Rogers' proposed acquisition of Shaw.
  • The Bureau alleges that removing a strong regional competitor like Shaw will likely result in consumers paying significantly higher wireless prices.

Awarding of an honorary doctorate - UQAT honours Robert Kanatewat's exceptional record in defending and promoting First Peoples' rights

Retrieved on: 
Monday, May 30, 2022
Cree Nation of Chisasibi, Self-management, Politics, Education, Universitate metro station, Indigenous, Housing, Assembly, School, Nation, Indigenous peoples, Institution, University, Empowerment, Economic development, UQAT, QC, Lieutenant, Management, Cree

A Cree politician and entrepreneur who is deeply involved in his community, Mr. Kanatewat has been an active participant in the societal debates on Indigenous issues in recent decades.

Key Points: 
  • A Cree politician and entrepreneur who is deeply involved in his community, Mr. Kanatewat has been an active participant in the societal debates on Indigenous issues in recent decades.
  • At that time, he was Chief of the Cree Nation of Chisasibi, a position he held from 1968 to 1977.
  • "In recognition of his political and community involvement as well as his significant contribution as an ambassador for the respect and recognition of Indigenous rights, UQAT wishes to acknowledge Mr. Robert Kanatewat's exceptional career by awarding him an honorary doctorate.
  • The honorary doctorate, also known as a doctorate honoris causa, is the highest distinction that the University can award.

Validation of medical technologies in the context of care - A new consortium to facilitate the marketing and export of Quebec expertise

Retrieved on: 
Monday, May 30, 2022
Knowledge, CTS, Consortium, Investment, Incubator, Government, Research, NanoFlowcell, Industry, Program, District, Technology, Innovation, Admar Gonzaga, Growth, Laboratory, QC, ACET, Pharmaceutical industry, Management, CeNTech

In the long term, the consortium's support will facilitate the commercialization and export of Quebec's expertise in health technology and generate investments of nearly $100 million.

Key Points: 
  • In the long term, the consortium's support will facilitate the commercialization and export of Quebec's expertise in health technology and generate investments of nearly $100 million.
  • More concretely, this consortium will allow Quebec start-ups to be competitive with the biggest players in the industry and thus penetrate the international market.
  • Marketing in the health care system requires a lot of effort and a thorough knowledge of the industry.
  • Since their creation, the entire Consortium of Life Sciences Accelerators and Incubators has generated nearly $1 billion in investment.

Manac Inc. adds strength to The Power Team's bid to Modernize Canada's Logistics Vehicle Fleet

Retrieved on: 
Monday, May 30, 2022
CAF, LVM, ABS, Logistics, Family, The Power Team (TV series), K-Line, Canadian Armed Forces, CPS, Light, Calyptronoma, Power Team, Laurier-Station, Quebec, Defense, Heavy Equipment Transport System, Heavy, Val-des-Sources, Les Knight, Peerless Motor Company, General Dynamics Land Systems, MO, CEO, Heavy equipment, Online shopping, BC, QC

Manac, Canada's largest and most diverse trailer manufacturer, has selected K-Line Trailers to build the Heavy Equipment Transporters at their Langley, BC, plant.

Key Points: 
  • Manac, Canada's largest and most diverse trailer manufacturer, has selected K-Line Trailers to build the Heavy Equipment Transporters at their Langley, BC, plant.
  • "The Power Team with Manac and partners will deliver world-class trailer capabilities in their bid for Canada's Logistics Vehicle Modernization project," says Mr. Tom Ramsden,Vice-President Sales & Marketing for Manac.
  • The Logistics Vehicle Modernization project provides the Canadian Armed Forces ("CAF") with new fleets of light and heavy logistics vehicles, trailers, vehicle modules, and armour protection kits.
  • For more information about The Power Team's Logistics Vehicle Modernization solution, please see:
    Canadian Defence Review: LVM Update The Power Team: http://www.canadiandefencereview.com/featured_content?blog/225
    Link to The Power Team's LVM website: https://lvmteamgd.com
    Manac is the leading North American manufacturer of specialty trailers.